Moderna Inc

NASDAQ: MRNA
$108.85
+$0.96 (+0.9%)
Closing price April 24, 2024
Moderna Inc is a pioneering biotechnology firm based in Cambridge, Massachusetts, known for its innovative use of messenger RNA (mRNA) to develop vaccines and therapeutics. The company has made significant strides in addressing infectious diseases, including COVID-19, influenza, and more, as well as tackling challenges in immuno-oncology, rare diseases, autoimmune disorders, and cardiovascular diseases. Moderna's portfolio includes both respiratory and latent vaccines, public health vaccines, and treatments for infectious diseases. Additionally, it focuses on systemic secreted, cell surface therapeutics, cancer vaccines, and inhaled pulmonary therapeutics, supported by strategic alliances with global pharmaceutical leaders and research organizations.
A possible end to a long-running acquisition effort weighed on tech stocks Tuesday morning.
Friday's top analyst upgrades and downgrades included Beyond Meat, Carvana, Embraer, Lennar, Moderna, Paysafe, Peloton Interactive, PulteGroup, Ventas, VICI Properties and Vroom.
Tuesday’s top analyst upgrades and downgrades included Bloomin' Brands, Boston Beer, Bumble, Goldman Sachs, Juniper Networks, Merck, Moderna, Petco Health, Southern Company, Spirit Airlines and...
The Omicron variant of the coronavirus was having its way with global equity markets on Tuesday.
Despite Friday's sharp drop in equity prices, there were a couple of winners. Premarket trading indicated a higher open, with crude oil up well over 5%.
Tuesday's top analyst upgrades and downgrades included Airbnb, Canopy Growth, Continental Resources, DraftKings, Fisker, Moderna, Owens Corning, SunPower and Wayfair.
Here's a preview of three companies scheduled to report quarterly earnings before markets open Thursday.
Friday's top analyst upgrades and downgrades included Boeing, Cinemark, Freeport McMoRan, Intel, Moderna, Nvidia, Southwest Airlines, Urban Outfitters and Zoom Video.
Friday afternoon's analyst upgrades and downgrades included Chubb, Domino’s, Lam Research, Moderna, Riot Blockchain and more.
Vaccine maker Moderna has announced it is working on a new vaccine, and another COVID-19 treatment is getting hammered.
Here's a look at how August's most-discussed stocks on WallStreetBets performed in the month. Sometimes, talk is not cheap.
Friday’s top analyst upgrades and downgrades included BP, Cloudflare, Expedia, FireEye, Marathon Oil, Moderna, Pinduoduo, Vertex Pharmaceuticals and ViacomCBS.
COVID-19 vaccine maker Moderna, silver miner Hecla, and entertainment giant ViacomCBS are scheduled to report quarterly results before markets open Thursday morning.
Our earnings preview for Wednesday afternoon and Thursday morning includes a COVID-19 vaccine maker, a chipmaker and a company that designs and builds hydrogen fuel cells.
Here, 24/7 Wall St. has put together a preview of a few of the most anticipated quarterly reports due this week, including those from Airbnb, Best Buy, Home Depot, Moderna, Nvidia and Salesforce.